The new CanG law has opened the floodgates for proactive marketing towards new cannabis patients. Prescriptions are now available starting from 1€, necessary consultations and the shipping of medical cannabis take place entirely online, and rappers are promoting the whole thing. Is this in the interests of healthcare and patients? What do healthcare professionals and pharmaceutical companies say about this? And what is the position of the companies involved?
Moderator
Speakers
- Marla Luther
- Niels Lutzhoeft
- Gero Kohlhaas
- Matthias Fischer
- Janosch W. Kratz